title: Long-term follow-up of Philadelphia chromosome-positive (Ph) chronic myeloid leukaemia (CML) in children and adolescents managed at a single institution over a 20-year period.
authors.forename: Fiorina
authors.initials: F
authors.lastname: Giona
authors.forename: Maria Luisa
authors.initials: ML
authors.lastname: Moleti
authors.forename: Ilaria
authors.initials: I
authors.lastname: Del Giudice
authors.forename: Anna Maria
authors.initials: AM
authors.lastname: Testi
authors.forename: Daniela
authors.initials: D
authors.lastname: Diverio
authors.forename: Maria Rosaria
authors.initials: MR
authors.lastname: De Cuia
authors.forename: Franco
authors.initials: F
authors.lastname: Mandelli
authors.forename: Robin
authors.initials: R
authors.lastname: Foa
mesh_terms: D000293:Adolescent; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002648:Child; D005260:Female; D005500:Follow-Up Studies; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D008297:Male
chemical_list: D000970:Antineoplastic Agents; D016898:Interferon-alpha